Infosys co-founders chip in to shelter flood-hit victimsOctober 9th, 2009 BANGALORE - Four co-founders of IT bellwether Infosys Technologies collectively contributed Rs.10 crore to rebuild houses for the victims of flood havoc in north Karnataka recently, a top official said. "The company has pledged Rs.20 crore while four co-founders have volunteered to contribute Rs.2.5 crore each to the effort to build 3,000 pucca (permanent) houses for the flood-affected people," Infosys chief executive S.
Infosys, Biocon to build houses for flood-hit in KarnatakaOctober 8th, 2009 BANGALORE - India's IT bellwether Infosys Technologies Ltd and biotechnology major Biocon Ltd pledged to re-build around 6,000 houses at a cost of Rs.60 crore for the flood-affected people of north Karnataka, Chief Minister B.S. Yeddyurappa said Thursday.
DLF net profit down 79 percent in first quarterJuly 31st, 2009 MUMBAI - Realty major DLF Friday reported a 79 percent drop in its net profit to Rs.396 crore for the quarter ended June 30 from Rs.1,863.97 crore in the same quarter, the previous fiscal. The company's total income also slipped to Rs.1,649.86 crore, a 57 percent drop from the previous corresponding quarter's Rs.3,810.62 crore.
UK manufacturing output falls 1.2 percent in March-May quarter, dampens hopes of recoveryJuly 7th, 2009 UK mfg output down 1.2 percent in quarterLONDON — The government is reporting that U.K. manufacturing output fell by 1.2 percent in the March-May quarter compared to the previous three months.
Biocon announces strategic collaboration with MylanJune 29th, 2009 BANGALORE - Biocon Limited today announced that it has executed a definitive agreement with Mylan Inc. for an exclusive collaboration on the development, manufacturing, supply and commercialization of multiple, high value generic biologic compounds for the global marketplace.
Biocon to fund innovation cell at Hyderabad B-schoolJune 8th, 2009 BANGALORE - India's biotechnology major Biocon Ltd. Monday announced the setting up of a cell for innovation management at Hyderabad's Indian School of Business (ISB) with a corpus of Rs.1 crore.
Biocon inks partnership with ISB to launch Biocon Cell for Innovation ManagementJune 8th, 2009 BANGALORE - Biocon Limited have launched the Biocon Cell for Innovation Management (BCIM) to promote innovation in business. The Cell will be established under the aegis of the Centre for Leadership, Innovation, and Change (CLIC) at the ISB.
Kiran Mazumdar Shaw awarded prestigious 'Nikkei Asia Prize' 2009May 11th, 2009 BANGALORE - Kiran Mazumdar Shaw, Chairman and Managing Director, Biocon Limited has been honoured with the 'Nikkei Asia Prize' 2009 for Regional Growth. Japan's prestigious business daily Nihon Keizai Shimbun (Nikkei) awards Nikkei Asia Prizes annually to individuals or institutions from Asia Pacific region recognizing outstanding achievements that improve the quality of life in Asia.
Biocon last quarter profit dips 61 percentApril 28th, 2009 BANGALORE - Biotechnology major Biocon Tuesday announced a decrease of over 61 percent in its net profit for the quarter ending March 31. In a regulatory statement, Biocon said its unaudited net profit for the last quarter was Rs.241.4 million, compared to Rs.620.3 million - a decrease of over 61 percent.
Biocon Group delivers 16 per cent growth in operating profitsApril 28th, 2009 BANGALORE - Biocon Limited today announced its financial performance for the financial year ended March 31. Unpredictable rupee depreciation induced by the global economic crisis has adversely impacted consolidated FY '09 earnings, wherein losses of Rs.
Weak rupee lowers Biocon net profit 80 percent in 2008-09April 28th, 2009 BANGALORE - A steady weakening of the rupee in the volatile currency market has lowered the consolidated net profit of biotechnology major Biocon group to Rs.93.1 crore in 2008-09 from Rs.464 crore the year before, registering a whopping decline of 80 percent. 'Unpredictable rupee depreciation induced by global economic crisis has adversely impacted our consolidated earnings wherein losses of Rs.147 crore on account of mark-to-market (MTM) were provided,' Biocon chairperson Kiran Mazumdar-Shaw told reporters here Tuesday.
Bristol-Myers Squibb, Biocon's Syngene open new R and D facility at Biocon ParkMarch 23rd, 2009 BANGALORE - Syngene International, a subsidiary of Indian biotechnology major, BIOCON Ltd, and Bristol-Myers Squibb Company announced today the opening of a fully dedicated research and development facility for Bristol-Myers Squibb in Biocon Park, Bangalore. The 200,000 square-foot facility at Biocon Park is dedicated to helping advance Bristol-Myers Squibb's work in discovery and early drug development, and is currently occupied by 270 researchers.
India's GDP growth drops to 5.3 percent in third quarterFebruary 27th, 2009 NEW DELHI - The growth of India's gross domestic product (GDP) dropped to 5.3 percent in the third quarter ending Dec 31 last year, compared to a growth of 8.9 percent in the same period the previous year. The economy, usually equated to the GDP, had grown by 7.6 percent in the second quarter of this fiscal.
R-Com net up 2.7 percent in third quarterJanuary 22nd, 2009 NEW DELHI - Reliance Communications (R-Com), part of the Reliance-Anil Dhirubhai Ambani Group (R-ADAG), Friday reported 2.7 percent increase in net profit in the quarter ended Dec 31. The company posted Rs.14.1 billion (Rs.1,410 crore) net profit in the quarter as against Rs.13.73 billion a year earlier, an official statement said.
Wipro's attrition rate soars in third quarterJanuary 20th, 2009 BANGALORE - India's third largest IT bellwether lost more employees than it could hire during the third quarter this fiscal, a senior executive admitted Wednesday. 'Yes, our net addition of employees was less than gross addition in the global IT services and products business due to slowdown and attrition in the third quarter compared to second quarter,' Wipro human resources head Pratik Kumar told IANS here.
Loading ...